Kristen Pierce serves as Chief Development Officer at CERO THERAPEUTICS HOLDINGS, INC., where they oversee executive responsibilities. Since joining the company, Kristen Pierce has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 7, 2026 involved receiving (via award) 1,612,099 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 7, 2026 | CERO | $0 | Award | 1,612,099 | $N/A | Discretionary |
Kristen Pierce currently holds 1,612,099 shares of CERO THERAPEUTICS HOLDINGS, INC. (CERO), valued at approximately $0. This represents their equity stake as Chief Development Officer.
Based on SEC Form 4 filings, Kristen Pierce has been a net neutral trader of CERO stock. They have purchased $0 and sold $0 worth of shares.
Kristen Pierce's most recent insider trade was on Jan 7, 2026, when they sold 1,612,099 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted